Review of 2024 and previewing 2025

CELL AND GENE THERAPY INSIGHTS

December 2024

Review of 2024 and previewing 2025

Download PDF

Innovator Insight

Generation of novel AAV serotypes with enhanced infectivity, specificity, and lower toxicity via AAV capsid engineering platform

Generation of novel AAV serotypes with enhanced infectivity, specificity, and lower toxicity via AAV capsid engineering platform

Y Bu, Y Pan, Y Zhong et al.

Expert Roundtable

Preparing for success in gene therapy purification

Preparing for success in gene therapy purification

X Fu, A Sharma, A D Tustian et al.

Preparing for success in gene therapy analytical development

Preparing for success in gene therapy analytical development

Yan Zhi, Jing Li, Andres Castillo

Viewpoint

Bio-printing in the context of end-to-end scalable tissue-engineered ATMP manufacturing

Bio-printing in the context of end-to-end scalable tissue-engineered ATMP manufacturing

Isaak Decoene, Ioannis Papantoniou

Industrializing cell therapy: how to bring curative therapies to all patients who need them?

Industrializing cell therapy: how to bring curative therapies to all patients who need them?

Overcoming the senescence barrier in stem cell expansion

Overcoming the senescence barrier in stem cell expansion

William Ying Khee Hwang